Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Biotechnol ; 36(4): 346-351, 2018 04.
Article in English | MEDLINE | ID: mdl-29505028

ABSTRACT

Infiltration, accumulation, and survival of chimeric antigen receptor T (CAR-T) cells in solid tumors is crucial for tumor clearance. We engineered CAR-T cells to express interleukin (IL)-7 and CCL19 (7 × 19 CAR-T cells), as these factors are essential for the maintenance of T-cell zones in lymphoid organs. In mice, 7 × 19 CAR-T cells achieved complete regression of pre-established solid tumors and prolonged mouse survival, with superior anti-tumor activity compared to conventional CAR-T cells. Histopathological analyses showed increased infiltration of dendritic cells (DC) and T cells into tumor tissues following 7 × 19 CAR-T cell therapy. Depletion of recipient T cells before 7 × 19 CAR-T cell administration dampened the therapeutic effects of 7 × 19 CAR-T cell treatment, suggesting that CAR-T cells and recipient immune cells collaborated to exert anti-tumor activity. Following treatment of mice with 7 × 19 CAR-T cells, both recipient conventional T cells and administered CAR-T cells generated memory responses against tumors.


Subject(s)
Cell- and Tissue-Based Therapy , Chemokine CCL19/administration & dosage , Interleukin-7/administration & dosage , Receptors, Antigen, T-Cell/administration & dosage , Receptors, Chimeric Antigen/administration & dosage , Allografts , Animals , Cell Line, Tumor , Cell Survival/drug effects , Chemokine CCL19/genetics , Dendritic Cells/immunology , Dendritic Cells/transplantation , Gene Expression Regulation/drug effects , Interleukin-7/genetics , Mice , Receptors, Antigen, T-Cell/immunology , Receptors, Chimeric Antigen/immunology
2.
Exp Eye Res ; 146: 1-6, 2016 05.
Article in English | MEDLINE | ID: mdl-26689751

ABSTRACT

The chemokine receptor CCR7 is essential for migration of mature dendritic cells (DCs) to the regional lymph nodes, and it has been shown that blocking of CCR7 improves graft survival after high-risk corneal transplantation in vascularized recipient corneas. However, it is so far unknown whether blocking of CCR7 reduces migration of DCs from the avascular cornea to the draining lymph nodes and whether this leads to improved graft survival also in the low-risk setting of corneal transplantation, which accounts for the majority of perforating transplantations performed. Therefore, in this study, pellets containing Freund's adjuvant and bovine serum albumin (BSA) conjugated to Alexa488 fluorescent dye were implanted into the corneal stroma of BALB/c mice to analyze antigen uptake by corneal DCs and their migration to the regional lymph nodes. After pellet implantation, mice were either treated by local administration of a CCR7 blocking fusion protein that consisted of CCL19 fused to the Fc part of human IgG1 or a control-IgG. In vivo fluorescence microscopy showed uptake of Alexa488-conjugated BSA by corneal DCs within 8 h. Furthermore, analysis of single cell suspensions of draining lymph nodes prepared after 48 h revealed that 2.1 ± 0.3% of CD11c(+) cells were also Alexa488(+). Importantly, DC migration was significantly reduced after topical administration of CCL19-IgG (1.2 ± 0.2%; p < 0.05). To test the effect of CCR7 blockade on graft rejection after allogeneic low-risk keratoplasty, corneal transplantations were performed using C57BL/6-mice as donors and BALB/c-mice as recipients. Treatment mice received two intraperitoneal loading doses of CCL19-IgG prior to transplantation, followed by local treatment with CCL19-IgG containing eye drops for the first two weeks after transplantation. Control mice received same amounts of control-IgG. Kaplan-Meier survival analysis showed that in the CCL19-IgG treated group, 76% of the grafts survived through the end of the 8 week observation period, whereas 38% of the grafts survived in the control group (p < 0.05). Taken together, our study shows that blockade of CCR7 reduces the migration of mature corneal DCs to the draining lymph nodes and leads to improved graft survival in low-risk corneal transplantation.


Subject(s)
Chemokine CCL19/administration & dosage , Corneal Transplantation , Dendritic Cells/pathology , Graft Rejection/immunology , Graft Survival/immunology , Lymph Nodes/immunology , Receptors, CCR7/antagonists & inhibitors , Animals , Cell Differentiation , Cell Movement , Dendritic Cells/immunology , Disease Models, Animal , Female , Flow Cytometry , Graft Rejection/prevention & control , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Ophthalmic Solutions , Receptors, CCR7/metabolism
3.
J Immunol ; 195(1): 329-38, 2015 Jul 01.
Article in English | MEDLINE | ID: mdl-25994965

ABSTRACT

There is a lack of an HSV-2 vaccine, in part as the result of various factors that limit robust and long-term memory immune responses at the mucosal portals of viral entry. We previously demonstrated that chemokine CCL19 augmented mucosal and systemic immune responses to HIV-1 envelope glycoprotein. Whether such enhanced immunity can protect animals against virus infection remains to be addressed. We hypothesized that using CCL19 in a fusion form to direct an immunogen to responsive immunocytes might have an advantage over CCL19 being used in combination with an immunogen. We designed two fusion constructs, plasmid (p)gBIZCCL19 and pCCL19IZgB, by fusing CCL19 to the C- or N-terminal end of the extracellular HSV-2 glycoprotein B (gB) with a linker containing two (Gly4Ser)2 repeats and a GCN4-based isoleucine zipper motif for self-oligomerization. Following immunization in mice, pgBIZCCL19 and pCCL19IZgB induced strong gB-specific IgG and IgA in sera and vaginal fluids. The enhanced systemic and mucosal Abs showed increased neutralizing activity against HSV-2 in vitro. Measurement of gB-specific cytokines demonstrated that gB-CCL19 fusion constructs induced balanced Th1 and Th2 cellular immune responses. Moreover, mice vaccinated with fusion constructs were well protected from intravaginal lethal challenge with HSV-2. Compared with pgB and pCCL19 coimmunization, fusion constructs increased mucosal surface IgA(+) cells, as well as CCL19-responsive immunocytes in spleen and mesenteric lymph nodes. Our findings indicate that enhanced humoral and cellular immune responses can be achieved by immunization with an immunogen fused to a chemokine, providing information for the design of vaccines against mucosal infection by HSV-2 and other sexually transmitted viruses.


Subject(s)
Chemokine CCL19/immunology , Herpes Genitalis/prevention & control , Herpesvirus 2, Human/immunology , Vaccines, DNA/immunology , Viral Envelope Proteins/immunology , Viral Vaccines/immunology , Amino Acid Motifs , Animals , Chemokine CCL19/administration & dosage , Chemokine CCL19/genetics , Female , Herpes Genitalis/immunology , Herpes Genitalis/mortality , Herpes Genitalis/pathology , Herpesvirus 2, Human/chemistry , Immunity, Cellular/drug effects , Immunity, Mucosal/drug effects , Immunization , Immunoglobulin A/biosynthesis , Immunoglobulin G/biosynthesis , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Plasmids/administration & dosage , Plasmids/immunology , Recombinant Fusion Proteins/administration & dosage , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Survival Analysis , Th1-Th2 Balance , Vaccines, DNA/administration & dosage , Vaccines, DNA/genetics , Vagina/immunology , Vagina/pathology , Vagina/virology , Viral Envelope Proteins/administration & dosage , Viral Envelope Proteins/genetics , Viral Vaccines/administration & dosage , Viral Vaccines/genetics
4.
Acta Pharmacol Sin ; 34(3): 432-40, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23334235

ABSTRACT

AIM: To investigate how co-delivery of the gene encoding C-C chemokine ligand-19 (CCL-19) affected the systemic immune responses to an anti-caries DNA vaccine pCIA-P in mice. METHODS: Plasmid encoding CCL19-GFP fusion protein (pCCL19/GFP) was constructed by inserting murine ccl19 gene into GFP-expressing vector pAcGFP1-N1. Chemotactic effect of the fusion protein on murine dendritic cells (DCs) was assessed in vitro and in vivo using transwell and flow cytometric analysis, respectively. BALB/c mice were administered anti-caries DNA vaccine pCIA-P plus pCCL19/GFP (each 100 µg, im) or pCIA-P alone. Serum level of anti-PAc IgG was assessed with ELISA. Splenocytes from the mice were stimulated with PAc protein for 48 h, and IFN-γ and IL-4 production was measured with ELISA. The presence of pCCL19/GFP in spleen and draining lymph nodes was assessed using PCR. The expression of pCCL19/GFP protein in these tissues was analyzed under microscope and with flow cytometry. RESULTS: The expression level of CCL19-GFP fusion protein was considerably increased 48 h after transfection of COS-7 cells with pCCL19/GFP plasmids. The fusion protein showed potent chemotactic activity on DCs in vitro. The level of serum PAc-specific IgG was significantly increased from 4 to 14 weeks in the mice vaccinated with pCIA-P plus pCCL19/GFP. Compared to mice vaccinated with pCIA-P alone, the splenocytes from mice vaccinated with pCIA-P plus pCCL19/GFP produced significantly higher level of IFN-γ, but IL-4 production had no significant change. Following intromuscular co-delivery, pCCL19/GFP plasmid and fusion protein were detected in the spleen and draining lymph nodes. Administration of CCL19 gene in mice markedly increased the number of mature DCs in secondary lymphoid tissues. CONCLUSION: CCL19 serves as an effective adjuvant for anti-caries DNA vaccine by inducing chemotactic migration of DCs to secondary lymphoid tissues.


Subject(s)
Chemokine CCL19/genetics , Chemotaxis/immunology , Dendritic Cells/immunology , Dental Caries/prevention & control , Lymph Nodes/immunology , Spleen/immunology , Vaccines, DNA/immunology , Animals , Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , COS Cells , Chemokine CCL19/administration & dosage , Chemokine CCL19/immunology , Chemotaxis/genetics , Chlorocebus aethiops , Cytokines/immunology , Dendritic Cells/cytology , Dental Caries/immunology , Dental Caries/microbiology , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Genetic Vectors , Green Fluorescent Proteins/genetics , Injections, Intramuscular , Mice , Plasmids , Recombinant Fusion Proteins/genetics , Streptococcus mutans/genetics , Streptococcus mutans/immunology , Transfection , Vaccines, DNA/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...